| Literature DB >> 32308472 |
Cecelia Valrie1,2, Alfonso Floyd1, India Sisler3, Rupa Redding-Lallinger4, Beng Fuh5.
Abstract
PURPOSE: Youth with sickle cell disease (SCD), a genetic disorder of red blood cells, may experience acute pain episodes lasting 2 to 3 days on average. While existing research has demonstrated associations between SCD pain and poor social functioning in youth with SCD, there are no data on whether symptoms of depression and anxiety modify the relationship between pain and functional outcomes in pediatric pain populations. It was hypothesized that more symptoms of depression and anxiety would exacerbate the relationship between high pain and poor social functioning in youth with SCD. PATIENTS AND METHODS: We conducted a cross-sectional study of 114 youth with SCD and their guardians assessing the youth's pain, social functioning, and symptoms of depression and anxiety.Entities:
Keywords: adolescents; children; functional outcomes; mental health; pain; sickle cell
Year: 2020 PMID: 32308472 PMCID: PMC7152544 DOI: 10.2147/JPR.S238115
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Demographic, Clinical, Pain, Psychological, and Social Functioning Data
| n | % | N | |
|---|---|---|---|
| Female | 64 | 56.14% | 114 |
| Genotype | |||
| HBSS | 53 | 46.49% | 114 |
| HBSC | 42 | 36.84% | 114 |
| HbSβ+ | 12 | 10.53% | 114 |
| HbSβ0 | 4 | 3.51% | 114 |
| Other | 3 | 2.63% | 114 |
| Prescribed Hydroxyurea | 51 | 45.13% | 113 |
| Age (years) | 11.55 | 3.01 | 8–17 |
| Pain Characteristics | |||
| Pain Frequency (Episodes/Yr) | 19.45 | 32.17 | 1–155 |
| Pain Duration (Days) | 3.71 | 8.74 | 0.01–90 |
| Pain Severity (0–10 scale) | 7.27 | 2.08 | 2–10 |
| Psychological Symptoms | |||
| Depression | 49.23 | 8.77 | 40–81 |
| Anxiety | 51.44 | 10.37 | 35–77 |
| Social Functioning | |||
| Social Skills | 53.21 | 9.10 | 23–63 |
| Interpersonal Skills | 49.54 | 10.21 | 22–70 |
Note: N = 114 for continuous variables.
Abbreviation: yr, year.
Comparison of Social Functioning by Sex, SCD Genotype, and Hydroxyurea Use
| Guardian-Reported Social Skills | ||||
|---|---|---|---|---|
| M | SD | t | p-value | |
| Sex | ||||
| Female | 51.06 | 10.05 | −1.82 | 0.07 |
| Male | 47.60 | 10.18 | ||
| Genotype | ||||
| Severe | 47.35 | 9.46 | 2.34 | 0.02 |
| Moderate | 51.74 | 10.53 | ||
| Hydroxyurea | ||||
| Yes | 48.31 | 9.91 | 1.14 | 0.26 |
| No | 50.52 | 10.50 | ||
| Sex | ||||
| Female | 50.75 | 10.69 | 3.70 | < 0.01 |
| Male | 56.36 | 5.09 | ||
| Genotype | ||||
| Severe | 51.75 | 10.17 | 1.72 | 0.09 |
| Moderate | 54.67 | 7.70 | ||
| Hydroxyurea | ||||
| Yes | 52.90 | 8.83 | 0.27 | 0.79 |
| No | 53.37 | 9.42 | ||
Notes: For genotype, severe = HBSS or HbSβ0; moderate = HBSC or HbSβ+ or other.
Abbreviation: SCD, sickle cell disease.
Regression Models Predicting Social Functioning (N = 114)
| Guardian-Reported Social Skills | Self-Reported Interpersonal Skills | |||||
|---|---|---|---|---|---|---|
| β | t | Partial R2 | β | t | Partial R2 | |
| Female | 3.92 | 2.07* | 0.03 | −4.35 | −2.95** | 0.05 |
| HBSS or HbSβ0 | −5.64 | −2.96** | 0.07 | −2.56 | −1.72 | 0.02 |
| Pain Frequency | −1.35 | −1.01 | 0.01 | −1.28 | −1.23 | 0.01 |
| Pain Duration | −1.78 | −1.40 | 0.02 | −0.50 | −0.50 | 0.00 |
| Pain Severity | −0.84 | −0.90 | 0.01 | −1.49 | −2.03* | 0.03 |
| Depression | −2.19 | −1.71 | 0.02 | −3.22 | −3.23** | 0.06 |
| Anxiety | 2.60 | 2.05* | 0.03 | 0.39 | 0.39 | 0.00 |
| Pain Frequency x Dep | 0.26 | 0.26 | 0.00 | −0.85 | −1.09 | 0.01 |
| Pain Duration x Dep | −4.17 | −1.16 | 0.01 | −0.07 | 0.03 | 0.00 |
| Pain Severity x Dep | 1.04 | 0.83 | 0.01 | −1.59 | −1.62 | 0.02 |
| Pain Frequency x Anx | 0.31 | 0.22 | 0.00 | 3.00 | 2.75** | 0.04 |
| Pain Duration x Anx | 0.14 | 0.05 | 0.00 | 1.55 | 0.65 | 0.00 |
| Pain Severity x Anx | −0.90 | −0.69 | 0.00 | −0.11 | −0.11 | 0.00 |
Notes: **p < 0.01, *p < 0.05.
Abbreviations: Dep, Depression; Anx, Anxiety.
Figure 1Interaction between pain frequency and self-reported interpersonal skills at varying levels of anxiety symptoms.